Target intelligence / Profile preview

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12 (NDUFA12)

Target
NDUFA12
Molecular classification
Enzyme (accessory subunit of enzyme complex), Mitochondrial respiratory chain complex I component
01

Overview

NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12 (NDUFA12) is a nuclear-encoded accessory subunit of mitochondrial Complex I, the largest enzyme complex of the mitochondrial electron transport chain[1][2][3]. While not part of the catalytic core, NDUFA12 is essential for the assembly, stability, and function of Complex I, enabling the transfer of electrons from NADH to ubiquinone and proton translocation across the mitochondrial inner membrane[1][2][3]. Alterations or mutations in NDUFA12 are associated with mitochondrial complex I deficiency, leading to clinical phenotypes including Leigh syndrome, a severe neurodegenerative disorder[1][2][3]. NDUFA12 loss disrupts mitochondrial structure and function, illustrating its crucial role in energy metabolism and cellular homeostasis. Key points are based on authoritative gene function summaries and clinical genetics resources[1][2][3]. - [1]: NDUFA12 is not an enzymatic subunit but is required for Complex I stability and assembly. - [2]: Mutations in NDUFA12 can result in isolated Complex I deficiency, presenting as Leigh syndrome and other mitochondrial encephalopathies. - [3]: It plays no direct catalytic role but is indispensable for Complex I biogenesis and electron transport chain integrity. No drugs are currently known to directly target NDUFA12, but defects can act as biomarkers for diagnosis of mitochondrial diseases[1][2][3].

Other names
B17.2DAP13MC1DN23NADH:ubiquinone oxidoreductase subunit A1213 kDa differentiation-associated proteinComplex I-B17.2complex I B17.2 subunit
02

Biological functions

Electron transportOxidative phosphorylationATP generationMitochondrial respiratory chain assembly/stability
03

Disease associations

Mitochondrial complex I deficiencyLeigh syndromeLeukoencephalopathy, progressive, with ovarian failure
04

Safety considerations

Potential for severe mitochondrial dysfunction and neurodegeneration if disrupted
05

Biomarkers

Mutation in NDUFA12 for diagnosis of mitochondrial complex I deficiency and Leigh syndrome

Beyond the preview

Go deeper on NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12 (NDUFA12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADH dehydrogenase (ubiquinone) 1 alpha subcomplex subunit 12 (NDUFA12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call